What is the current valuation of the US animal model market?

The market valuation was $444.47 Million in 2024. Read More

What is the projected market size for the US animal model market by 2035?

The market is projected to reach $947.17 Million by 2035. Read More

What is the expected CAGR for the US animal model market during the forecast period 2025 - 2035?

The expected CAGR is 7.12% during the forecast period. Read More

Which animal types contribute significantly to the US animal model market?

Mice, with a valuation range of $264.47 Million to $587.17 Million, are a major contributor. Read More

What technologies are driving growth in the US animal model market?

CRISPR technology is projected to grow from $100 Million to $250 Million. Read More

What are the primary applications of animal models in the US market?

Research and Development applications accounted for $177.78 Million to $377 Million. Read More

Who are the key players in the US animal model market?

Key players include Charles River Laboratories, Envigo, and Taconic Biosciences. Read More

What role do pharmaceutical companies play in the US animal model market?

Pharmaceutical companies are projected to contribute $222.23 Million to $469.45 Million. Read More

How do educational institutes impact the US animal model market?

Educational institutes are expected to account for $44.45 Million to $95.12 Million. Read More

What is the significance of contract research organizations in the US animal model market?

Contract research organizations are projected to generate $110.9 Million to $239.48 Million. Read More

US Animal Model Market

US Animal Model Market Research Report: Size, Share, Trend Analysis By Animal Type (Pigs, Cats, Mice), By Technology (CRISPR, Microinjection, Embryonic Stem Cell Injection), By Applications (Research & Development, Production, Quality Control) and By End-User (Research Institutes, Educational Institutes, Pharmaceutical Companies, Contract Research Organizations) - Growth Outlook & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

7.12%

2024 Market Size

$ 444.47 Million

2035 Market Size

$ 947.17 Million

Pharmaceutical ● Updated July 2026 Report ID: MRFR/Pharma/15206-HCR | Pages: 100 | Author: Vikita Thakur, Garvit Vyas

Summary Table of Contents Segmentation Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Medical Device, BY Animal Type (USD Million) | |
  1. 4.1.1 Pigs | |
  2. 4.1.2 Cats | |
  3. 4.1.3 Mice |
2. 4.2 Medical Device, BY Technology (USD Million) | |
  1. 4.2.1 CRISPR | |
  2. 4.2.2 Microinjection | |
  3. 4.2.3 Embryonic Stem Cell Injection |
3. 4.3 Medical Device, BY Application (USD Million) | |
  1. 4.3.1 Research and Development | |
  2. 4.3.2 Production | |
  3. 4.3.3 Quality Control |
4. 4.4 Medical Device, BY End User (USD Million) | |
  1. 4.4.1 Research Institutes | |
  2. 4.4.2 Educational Institutes | |
  3. 4.4.3 Pharmaceutical Companies | |
  4. 4.4.4 Contract Research Organizations 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Medical Device | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Charles River Laboratories (US) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Envigo (US) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Taconic Biosciences (US) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Harlan Laboratories (US) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Laboratory Corporation of America Holdings (US) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Wuxi AppTec (CN) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Crown Bioscience (US) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 Inotiv (US) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 US MARKET ANALYSIS BY ANIMAL TYPE |
6. 6.3 US MARKET ANALYSIS BY TECHNOLOGY |
7. 6.4 US MARKET ANALYSIS BY APPLICATION |
8. 6.5 US MARKET ANALYSIS BY END USER |
9. 6.6 KEY BUYING CRITERIA OF MEDICAL DEVICE |
10. 6.7 RESEARCH PROCESS OF MRFR |
11. 6.8 DRO ANALYSIS OF MEDICAL DEVICE |
12. 6.9 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE |
13. 6.10 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE |
14. 6.11 SUPPLY / VALUE CHAIN: MEDICAL DEVICE |
15. 6.12 MEDICAL DEVICE, BY ANIMAL TYPE, 2024 (% SHARE) |
16. 6.13 MEDICAL DEVICE, BY ANIMAL TYPE, 2024 TO 2035 (USD Million) |
17. 6.14 MEDICAL DEVICE, BY TECHNOLOGY, 2024 (% SHARE) |
18. 6.15 MEDICAL DEVICE, BY TECHNOLOGY, 2024 TO 2035 (USD Million) |
19. 6.16 MEDICAL DEVICE, BY APPLICATION, 2024 (% SHARE) |
20. 6.17 MEDICAL DEVICE, BY APPLICATION, 2024 TO 2035 (USD Million) |
21. 6.18 MEDICAL DEVICE, BY END USER, 2024 (% SHARE) |
22. 6.19 MEDICAL DEVICE, BY END USER, 2024 TO 2035 (USD Million) |
23. 6.20 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
24. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
25. 7.2 US MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY ANIMAL TYPE, 2025-2035 (USD Million) | |
  2. 7.2.2 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  3. 7.2.3 BY APPLICATION, 2025-2035 (USD Million) | |
  4. 7.2.4 BY END USER, 2025-2035 (USD Million) |
26. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.3.1 |
27. 7.4 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

US Animal Model Market Segmentation

US Animal Model Market By Animal Type (USD Million, 2025-2035)

Pigs
Cats
Mice

US Animal Model Market By Technology (USD Million, 2025-2035)

CRISPR
Microinjection
Embryonic Stem Cell Injection

US Animal Model Market By Application (USD Million, 2025-2035)

Research and Development
Production
Quality Control

US Animal Model Market By End User (USD Million, 2025-2035)

Research Institutes
Educational Institutes
US Animal Model Market Companies
Contract Research Organizations

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”